AI is accelerating insurance claim denials in otolaryngology, causing increased administrative burdens and patient care delays, with physicians responding by developing and using AI tools to improve documentation and appeals.
TMRT offers significant advantages over conventional tympanoplasty, including shorter operative time, greater hearing improvement, and higher patient satisfaction, while achieving comparable closure rates.
In WAYPOINT, tezepelumab produced early and sustained improvements in patient-reported and objective smell outcomes compared with placebo, and markedly reduced the proportion of patients with UPSIT-defined anosmia.
Early ESS was associated with lower rates of moderate and severe persistent asthma, fewer asthma exacerbations, and reduced utilization of systemic steroids, LABAs, and biologic therapies compared with delayed surgery.
The 2026 president of the Triological Society, Michael G. Stewart, highlights the Society’s longstanding leadership in otolaryngology, its support for publications, scientific meetings, and research funding, and introduces new initiatives including the ELEVATE-ENT program and the TRIO Leadership Academy.
Dr. Holt discusses the ethical obligation of otolaryngologists to promptly report diagnostic test results to patients to alleviate anxiety and maintain trust.
Universal newborn screening identifies more children with cCMV, but exclusion of these children from daycare is unsupported by evidence, exacerbates inequities, and is ineffective in reducing transmission.